Liberec

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Liberec

What is Liberec? (Loratadine)

Property Description
Active Ingredient Loratadine
Pharmacological Class Second-generation Antihistamine
Common Forms Tablet, Oral Solution, Syrup
Route of Administration Oral
Origin Synthetic

What Type of Medicine is Liberec (Loratadine)?

Liberec is a pharmaceutical preparation classified as a second-generation antihistamine, recognized for providing systemic relief from allergic symptoms. Its core identity is based on the active ingredient, Loratadine, a chemically synthesized compound categorized as a H1-receptor antagonist. Loratadine is clinically recognized for its high selectivity for peripheral receptors, demonstrating limited cross-reactivity with the central nervous system. This means the medicine addresses allergy discomfort while successfully minimizing the potential for causing notable drowsiness.


Liberec's Composition and General Purpose

Liberec is a single-ingredient product designed for oral administration, commonly found as a tablet, syrup, or oral solution. As an INN, Loratadine is the sole active substance in this formulation. The multiple available forms, including the liquid syrup for easier administration to pediatric groups, reflect its broad intended application. The medication is used for its activity against histamine-induced responses and its favorable, long-acting profile. This long-acting action is useful because it provides sustained relief from common discomforts associated with hypersensitivity reactions. The primary therapeutic role of the medication is to mitigate uncomfortable physiological responses—such as itching and swelling—that are naturally triggered by the body’s release of histamine during an allergic event.

Regulatory References

  1. Loratadine: MedlinePlus Drug Information

What side effects are possible with Liberec?

Possible side effects and safety information for Liberec (Loratadine)

The official safety profile for Liberec is categorized by frequency and the physiological system affected, as documented in government regulatory sources. Adverse reactions are classified based on controlled clinical trial data and subsequent post-marketing reports.

Frequency-Classified Adverse Reactions

The most commonly documented side effects reported in excess of placebo include headache, somnolence (drowsiness), fatigue, dry mouth, increased appetite, and insomnia. Side effects are grouped into System-Organ-Classes, including Nervous System Disorders, Metabolism and Nutrition Disorders, and Gastrointestinal Disorders.

Serious Adverse Reactions and Constraints

Rare, but clinically significant events are documented, primarily from post-marketing surveillance, and are classified as Very Rare. These include severe hypersensitivity reactions such as anaphylaxis and angioedema, as well as reports of abnormal hepatic function (e.g., jaundice, hepatitis) and convulsion.

The regulatory label includes specific safety constraints. Patients must discontinue the medicine at least 48 hours before undergoing skin allergy testing, as the drug can interfere with results. Though generally non-sedating, individuals who experience somnolence should use caution when performing skilled tasks like driving or operating machinery.

Population-Specific Safety Statements

Specific considerations apply to certain populations. Use during lactation is contraindicated because Loratadine is excreted in breast milk. Use in pregnancy is generally not recommended as a precautionary measure. Caution and potential dosage adjustment are required for patients with severe hepatic impairment, as clearance of the medicine may be reduced.

Overdose and Emergency Response

Overdose and when to seek help

An overdose of Liberec (Loratadine) is officially documented by regulatory authorities to present with specific clinical signs. These documented overdose manifestations include somnolence (sleepiness or drowsiness), a rapid heart rate known as tachycardia, and headache. Other signs, such as general fatigue and an increased occurrence of anticholinergic symptoms, have also been reported in clinical cases of overexposure.

Required Emergency Actions

In any suspected overdose situation, official government guidance mandates that the individual seek medical help immediately or contact a Poison Control Center. Urgent emergency services must be contacted for severe, life-threatening symptoms, including having a seizure, experiencing trouble breathing, or if the individual has collapsed or cannot be awakened. Regulatory documents specify that following initial emergency treatment, continuous medical monitoring of the patient is to be continued.

Management and Limitations

Official prescribing information states that no specific antidote is known for Loratadine overdose. Management is therefore focused on general symptomatic and supportive measures. Procedures such as the administration of activated charcoal or gastric lavage may be considered by medical professionals. It is officially noted that the substance is not removed by haemodialysis. Individuals with severe liver or kidney impairment are advised to consult a healthcare provider regarding appropriate dosing to mitigate potential overdose risks.

Therapeutic Uses of Liberec

The medication is used in situations involving certain distressing symptoms across several key therapeutic domains. It is considered relevant in contexts involving heightened systemic burden.

Easing Intense Worry, Tension, and Nervousness

Liberec is commonly used for the short-term relief of symptoms of anxiety disorders and other anxiety-related manifestations. It is relevant in contexts marked by increased tension and nervousness, addressing symptom clusters that may interfere with daily comfort. The medication is commonly used to help with the emotional load, and supports general well-being during symptomatic phases.


Supportive Relief in Alcohol Withdrawal

This treatment is also applied in clinical settings for the management of the acute withdrawal symptoms of alcoholism. It helps address symptoms related to heightened physiological activity, such as severe agitation, muscle tremors, and acute restlessness. It is relevant when short-term symptomatic assistance is needed to support patients during difficult episodes by easing distress.


Quick Fact: Managing Spasm Symptoms

Quick Fact: Managing Spasm Symptoms

In certain combination formulations, the active ingredient may be part of symptomatic management in gastrointestinal disorders, including Irritable Bowel Syndrome (IBS). It is relevant for easing symptoms linked to organ-specific functional stress, which contributes to improved comfort during periods of heightened symptoms.

Eligibility and Restrictions for Use

The official regulatory profile for Liberec, which contains Loratadine, defines eligibility based on age, physiological status, and underlying comorbidities.

Eligibility Scope

Category Eligibility Rule (Regulatory Wording)
Contraindicated Populations Patients with known hypersensitivity to Loratadine or any excipients [Source 1.2].
Age-Related Eligibility Approved for use in adults and children 2 years of age and older. Use is not established for children younger than 2 years of age [Source 3.1, 3.2].
Conditional Use Patients with severe liver impairment (hepatic failure) or severe renal impairment (GFR <30 mL/min) are restricted to conditional use and require an increased dosing interval [Source 1.5].
Maternal Status Use is not recommended in breastfeeding women due to excretion of the substance into breast milk. Use is preferable to avoid during pregnancy as a precautionary measure [Source 1.2, 1.3].
Comorbidity Restriction Formulations containing aspartame (e.g., chewable tablets) are restricted for patients with Phenylketonuria (PKU) [Source 1.5, 2.2].

Eligibility Classifications (High-Level)

Official regulatory documents classify non-eligibility into specific categories:

  • Contraindicated: Hypersensitivity to the drug.
  • Not Established: Use in children younger than 2 years of age.
  • Not Recommended: Use during pregnancy and lactation.
  • Restricted/Conditional Use: Patients with severe hepatic or renal impairment.

These regulatory classifications strictly govern the population groups permitted, restricted, or prohibited from using the medicine under approved labeled conditions.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Official regulatory documents define the interaction profile of Liberec (Loratadine) based on pharmacokinetic changes, procedural constraints, and specific co-administration restrictions.

Pharmacokinetic Interactions

Co-administration with inhibitors of Cytochrome P450 (CYP) enzymes, particularly CYP3A4 and to a lesser extent CYP2D6, results in substantially increased plasma concentrations of Loratadine.

Interacting Substance Official Regulatory Effect
Ketoconazole Substantially increased Loratadine exposure
Erythromycin Substantially increased Loratadine exposure
Cimetidine Substantially increased Loratadine exposure
Food Increases systemic bioavailability (AUC) by 40-48%

Interaction Constraints and Considerations

The prescribing information notes specific constraints regarding diagnostic procedures and certain patient populations:

  • Timing Requirement: Administration must be discontinued at least 48 hours prior to allergy skin testing to prevent interference with test results.
  • Alcohol: Official studies show no potentiating effects on alcohol-related psychomotor performance.
  • Contraindicated Combination: The co-administration of Mavorixafor is not recommended by regulatory-based resources.
  • Hepatic Impairment: Loratadine exposure (AUC and Cmax) is approximately doubled in patients with severe chronic alcoholic liver disease.

Mechanism of Action

Targeted Blockade of Peripheral H1 -Receptors

The core mechanism involves the highly selective competitive antagonism of peripheral Histamine H1 -receptors on cell surfaces, particularly in vascular and nerve tissues. By binding to these receptors, Loratadine and its active metabolite, Desloratadine, prevent the endogenous mediator histamine from initiating its signaling cascade. This action results in the modulation of microvascular permeability and a reduction in sensory nerve signal transmission.


Physiological Selectivity and Sustained Action

The drug's chemical properties contribute to high physiological selectivity by limiting its passage across the blood-brain barrier ( BBB), which means H1 -receptors in the brain remain largely unaffected. The active metabolite, Desloratadine, extends the duration of the receptor blockade, which maintains sustained modulation of histamine-driven signaling. The mechanism also includes secondary inhibition of inflammatory mediator release from immune cells like mast cells, limiting the activation caused by high levels of mediator activity within targeted physiological pathways.

Dosage and Administration Information

Instruction Map: How to use Liberec (Loratadine)

This map outlines the instructions for the administration and dosing of Loratadine (Liberec).


Administration Scope

Instruction Detail
Route of administration Oral use is the recognized route for formulations, including tablets and oral solutions.
Dosing schedule Standard Adult Dose (and children ge 6 years): 10 mg once daily. Standard Pediatric Dose (2 to 5 years): 5 mg once daily. The maximum dose is 10 mg in any 24-hour period.
Timing in relation to meals The medicine may be taken without regard to mealtime (with or without food).
Age-group administration rules Severe Hepatic Impairment: For adults and children weighing over 30 kg, the initial dose is 10 mg every other day. Severe Renal Impairment (GFR <30 mL/ min): The dose is also reduced to 10 mg every other day for adults and children ge 6 years.
Missed-dose rules If a dose is missed, take it when remembered; however, do not take more than one dose in a 24-hour period.
Special procedural conditions Administration must be discontinued for at least 48 hours before a patient undergoes any allergy skin testing, as the medication may interfere with test results.

Instruction Classifications (High-Level)

Classification Principle
Administration method type Oral
Frequency pattern Once daily (qDay)
Basis Established Protocols
Use-context constraints Allergy Testing Constraint and Impairment Constraint (dose reduction required for severe hepatic or renal disease).

Resulting Procedural Structure

Step sequence:

  • Take the prescribed 5 mg or 10 mg dose of Liberec once every 24 hours.
  • Consume the dose orally; this may be done independently of meals.
  • Adhere to the 10 mg every other day schedule if diagnosed with severe hepatic or renal impairment.

Connection to the overall use protocol: The instructions establish a standardized once-daily oral use protocol designed to manage systemic exposure without exceeding the maximum 10 mg dosage. This structure incorporates timing constraints for allergy testing and dose reductions for patients with specific organ impairment, defining the administration requirements.

Recent Clinical Evidence

Research evidence / Overview of studies for Liberec (Loratadine)


Evidence for Use in Seasonal and Perennial Allergic Rhinitis

Research examined its potential role in allergic rhinitis, which includes symptoms commonly associated with hay fever and year-round allergies. The foundation of this evidence relies primarily on short-term, randomized controlled trials (RCTs). The studies monitored outcomes related to physical discomfort and included both adult and adolescent populations. The research examined key outcomes related to physical discomfort, specifically using standardized metrics to track the severity of symptoms like sneezing, nasal itching, runny nose, and eye discomfort.

In these trials, the research describes the process where researchers monitored patient-reported outcomes describing perceived discomfort and symptom scores compared to baseline. Research was evaluated in settings with varying symptom burdens, and the findings indicate patterns related to measured change in the symptom scoring metrics over the short-term study periods.


Evidence for Use in Chronic Idiopathic Urticaria (Hives)

The research explored its potential application in chronic idiopathic urticaria, which are conditions where symptoms may vary in intensity and persist for six weeks or more. This evidence primarily consists of randomized, controlled, short-term trials. Studies monitored outcomes related to physical discomfort, such as the number and size of hives (wheals) and the intensity of itching (pruritus). These studies included adults and adolescents whose conditions were characterized by fluctuating or episodic manifestations.

Studies focusing on episodes where symptoms become more noticeable reported how symptoms evolved in the observed populations compared to baseline measurements. Findings from meta-analyses reported a pattern observed in the studies when comparing the measurement of symptom suppression against several other second-generation agents.


What is Still Uncertain About Liberec’s Research Base

Research has been studied for different age groups, including pediatric populations, though the data for certain groups remain insufficient compared to the adult evidence base. Long-term effects are not fully established by the existing evidence, as follow-up durations were limited in many pivotal studies. Also, comparative evidence is lacking for the specific outcome of change in measurements for severe nasal congestion when compared to combination products containing a decongestant.

Key Studies & References

  1. H1-antihistamines for chronic spontaneous urticaria: an abridged Cochrane Systematic Review
  2. Loratadine and Desloratadine Use in Children (Pediatric Pharmacotherapy Review)
  3. Label: LORATADINE tablet (DailyMed - NIH)

Frequently Asked Questions (FAQ)

Common questions about Liberec (FAQ)


Q: How long does it typically take to see any effect from Liberec?

A: According to official product information and clinical data, the onset of action for symptom relief can begin relatively quickly, often reported to be in as little as 75 minutes. The full effects of the medicine are generally observed to reach their peak within 8 to 12 hours after the dose is taken.


Q: Is it normal to feel tired when starting Liberec?

A: Although Liberec (Loratadine) is classified as a non-sedating antihistamine, regulatory documents list both drowsiness (somnolence) and fatigue as common adverse reactions. These effects were reported to occur more frequently in people taking the medicine than in those taking a placebo in clinical trials.


Q: Is Liberec known to cause weight gain or loss?

A: Official safety data includes increased appetite as a frequently reported side effect from clinical trials. However, the regulatory documentation does not list weight gain or weight loss itself as a distinct, established adverse reaction of the drug.


Q: Does Liberec interact with common pain relievers like ibuprofen?

A: Authoritative patient information indicates that Liberec can typically be taken concurrently with common, non-prescription pain relievers such as ibuprofen or paracetamol. A specific adverse interaction between Loratadine and these pain medications has not been identified in the official product information.


Q: Why do doctors prescribe Liberec instead of other options?

A: Official information describes Liberec as a second-generation antihistamine with high peripheral selectivity. The drug's profile is noted for its generally low potential for causing sleepiness due to minimal penetration into the central nervous system, supporting its general use for allergy relief.


Q: Can Liberec interact with herbal remedies like St. John's Wort?

A: Regulatory-based interaction data suggests that the herbal remedy St. John's Wort may potentially reduce the effectiveness of Loratadine. This is because it can speed up the process by which the body breaks down the medicine in the liver.


Q: Why are there different strengths of Liberec?

A: The medicine is available in different strengths (e.g., 10 mg tablets and an oral solution) to safely accommodate different patient groups and their dosing requirements. This includes specific doses for adults versus children, and to allow for conditions where adjusted dosing intervals are required, such as for people with severe liver or kidney impairment.


Q: Can Liberec be crushed or split?

A: The official documentation for the standard tablet formulation describes it as intended to be swallowed whole and not to be crushed or broken. However, a specific formulation known as an orally disintegrating tablet (ODT) is designed to dissolve in the mouth without requiring water or chewing.


Q: Does Liberec interact with grapefruit juice?

A: General guidance from authoritative sources suggests that some acidic fruit juices, including grapefruit juice, may potentially reduce the absorption and effectiveness of the medicine. Official sources have described that separation of consumption is generally advised to ensure optimal absorption.


Q: Can Liberec cause hair loss?

A: Hair loss (medically known as alopecia) has been reported as an adverse event in post-marketing surveillance reports. These types of events are generally classified in official documents as occurring very rarely after the drug has been made available to the public.


Q: Do you have to take Liberec forever?

A: Clinical studies have provided data for treatment periods typically lasting up to six months. The official documents describe the medicine’s role as being for the management of allergic symptoms, indicating it is generally intended to be taken for the duration necessary to provide relief.


Q: Is Liberec the same as [Name of Competitor Drug]?

A: Liberec, which contains Loratadine, is classified in the same group of second-generation antihistamines as other drugs like cetirizine, but they are distinct medicines. While they treat similar conditions, they possess different chemical structures and may have different profiles, such as in onset of action or potential for drowsiness.


Q: Are there any specific foods to avoid while taking Liberec?

A: Official instructions state that the medicine can be taken without regard to food (with or without a meal). Although food is known to increase the overall exposure of the drug in the body, there are no specific foods that are explicitly restricted in the regulatory documentation.


Q: How long does Liberec stay in your system?

A: The parent drug, Loratadine, has an average elimination half-life of approximately 8 hours. Its active metabolite, Desloratadine, has a longer half-life of around 28 hours, which contributes to the drug's sustained effect. The medicine and its breakdown products are eliminated from the body through the kidneys and feces.


Q: Is there a generic version of Liberec available?

A: Yes, the active ingredient Loratadine is approved by regulatory agencies and is widely available as a generic drug. Since the drug was approved for Over-The-Counter (OTC) status, both brand-name products and generic Loratadine are sold without a prescription.


Q: Can I take vitamins or supplements with Liberec?

A: Official drug interaction lists primarily focus on prescription and non-prescription medicines. Regulatory documents generally lack specific data detailing known interactions with most vitamins or generic supplements, as these substances are not typically tested in the same way as approved drugs.


Q: What should I do if a side effect of Liberec bothers me?

A: Official patient guidance states that if a patient is experiencing a side effect that is persistent, causes discomfort, or is otherwise concerning, official guidance recommends consulting with a doctor or pharmacist for assessment.


Q: Can older adults take Liberec?

A: Yes, regulatory information indicates that Liberec is generally considered a preferred agent for use in older adults compared to older, more sedating antihistamines. Studies suggest that the body processes the drug similarly to younger adults. Dose adjustment is required only for those who also have severe liver or kidney impairment.


Q: Can Liberec affect blood pressure?

A: Clinical studies and safety data do not identify an effect on blood pressure as a common or established adverse reaction of the medicine. The drug is classified as having a low risk for affecting cardiovascular parameters, such as heart rate or blood pressure, when taken at recommended doses.


Q: What if I take too much Liberec?

A: Regulatory documents state that ingestion of doses significantly higher than recommended is a situation that requires professional medical assessment. Symptoms reported in cases of overdose can include fast heartbeat (tachycardia), drowsiness, or headache. Large overdoses are associated with the risk of cardiac arrhythmia.

How should Liberec be stored and disposed of?

Storage and Disposal Requirements for Liberec

The storage and disposal of Liberec (Loratadine) must comply strictly with the conditions defined in official regulatory documents to maintain product integrity and safety.

Labeled Storage Conditions

Item Requirement
Temperature Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F). Do not store above 25 C.
Protection Protect from excessive moisture, heat, and light. The medicine must not be allowed to freeze.
Container Keep the medicine in its original container and ensure the container is tightly closed.

Safety and Disposal

It is officially required that the medicine be stored out of the sight and reach of children to prevent accidental ingestion. Unused or expired Liberec must be disposed of according to local pharmaceutical waste handling requirements. It is advised not to dispose of the product in wastewater or general household waste unless directed by specific local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Liberec found in:

A-Z Index: